Companies in the news and how they were assessed

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Companies in the news and how they were assessed

Issue of the week: populism and central banks ...

CITY

Out of puff: Second-quarter revenue at Connecticut-based Marlboro-maker Philip Morris International (PMI) rose 7.1% from a year earlier, to $10.1bn – slightly short of analysts’ expectations of $10.3b

UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of 9,000, driven by a broad recovery in equity prices. To put it another way, the rally wasn’t just driven by a